| Bioactivity | Anticonvulsant agent 1 is an anticonvulsant agent extracted from patent WO2001062726A2, Compound 156. |
| Invitro | The inhibition constant (Ki) of Anticonvulsant agent 1 (Compound 156) is determined in competitive binding experiments by measuring the binding of a single concentration of a radioactive ligand at equilibrium with various concentrations of the unlabeled test substance. The concentration of the test substance inhibiting 50 % of the specific binding of the radioligand is called the IC50. The equilibrium dissociation constant Ki is proportional to the IC50 and is calculated. Anticonvulsant agent 1 shows pKi values of 6.0 and greater[1] |
| Name | Anticonvulsant agent 1 |
| CAS | 357336-17-5 |
| Formula | C10H14F2N2O2 |
| Molar Mass | 232.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Differding, Edmond, et al. 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES. WO2001062726A2 |